# Antibiotics: Materials

Source page: https://www.materialinsights.org/technologies/antibiotics/tech-materials/

#### Materials it needs

The commodities and chemicals it needs per unit, its share of each one's demand and how critical each is
 Made of

- [API Small-molecule APIs](https://www.materialinsights.org/chemicals/apis/) criticality high The active antibiotic ingredients are now made mostly in Asia: China supplied 70.1% of US imports of them by volume in 2024 ^[6].
 Uses

- [6APA Antibiotic intermediates (6-APA, 7-ACA)](https://www.materialinsights.org/chemicals/antibiotic_intermediates/) criticality high Many penicillins and cephalosporins are built from intermediates made by fermentation and then changed chemically; the United States can no longer make penicillin itself ^[6].
- [Exc Pharmaceutical excipients](https://www.materialinsights.org/chemicals/excipients/) criticality low Fillers and binders turn the active ingredient into tablets, capsules and syrups.
 Needs

- [Su Sugar](https://www.materialinsights.org/commodities/sugar/) criticality low Fermentation microbes are fed sugars and other nutrients to make the antibiotic.

as of 2026-11-10. No source gives material amounts per dose; criticality reflects how concentrated ingredient supply has become [6].

#### Critical materials

The materials whose supply could hold it back

- Active ingredients: China supplied 70.1% of US antibiotic ingredient imports by volume in 2024 ^[6].
- Shift of supply: Europe provided 75% of US antibiotic ingredient imports in 1992 and Asia 75% in 2024 ^[6].
- Penicillin: the United States can no longer produce key antibiotics such as penicillin and doxycycline at home ^[6].

as of 2026-11-10

#### Sources

1. [US relies heavily on China, other nations for antibiotics](https://www.cidrap.umn.edu/resilient-drug-supply/us-relies-heavily-china-other-nations-antibiotics) CIDRAP, University of Minnesota (reporting a Johns Hopkins study in JAMA Health Forum)

## Other sections

- [Summary](https://www.materialinsights.org/technologies/antibiotics/index.md)
- [Overview](https://www.materialinsights.org/technologies/antibiotics/tech-overview/index.md)
- [Science](https://www.materialinsights.org/technologies/antibiotics/tech-science/index.md)
- [Evolution](https://www.materialinsights.org/technologies/antibiotics/tech-evolution/index.md)
- [Energy footprint](https://www.materialinsights.org/technologies/antibiotics/tech-energy-footprint/index.md)
- [Industries](https://www.materialinsights.org/technologies/antibiotics/tech-industries/index.md)
